AWAK Technologies

About:

AWAK develops wearable dialysis machines that operate and function like a normal kidney, for continuous dialysis.

Website: http://www.awak.com

Top Investors: Vickers Venture Partners, Enterprise Singapore, Seeds Capital, Eckuity, Advanced MedTech

Description:

AWAK Technologies develop wearable dialysis machines, 1kg and battery-operated, for continuous dialysis. The company was certified by SGS for ISO 13485 Quality Management System in September 2008 with the scope of designing, manufacturing and distributing medical devices. The Automated Wearable Artificial Kidney (AWAK) is based on tidal peritoneal dialysis. The technology is based on research by Profs David Lee & Martin Roberts of UCLA and VA Systems. The engineering and development of AWAK is done in Singapore with the collaboration of Temasek Polytechnic. The company has completed the R&D and is now in the clinical trial stage, targeting both FDA and CE certifications. The AWAK Regular Cartridge, is currently in pilot production stage and expected to enter clinical trial by the end of 2012. This wearable artificial kidney operates continuously and functions like a normal kidney. Being small , light (less than 1 kg) and battery-operated, the patients will be able to go about having daily routines, with no restriction to lifestyles such as work, travel and leisure.